<p>Lovisa Farnebo completed her clinical training at Linköping University Hospital, Sweden. She presented her PhD thesis in 2010, and subsequently undertook a postdoctoral fellowship at Stanford University, California from 2011 to 2013. She was appointed Associate Professor in 2017.</p> <p>Her clinical practice and research focus on patients with head and neck cancer. She currently serves as the principal supervisor for five PhD students in this field.</p> <p>She served as President of the Swedish Society of Otorhinolaryngology–Head and Neck Surgery from 2021 to 2026 and is currently President of the Acta Foundation in Sweden.</p>

<p>Seiichi Yoshimoto, MD, PhD, graduated from the University of Tokyo in 1991 and completed his residency in otolaryngology at the same institution. In 1995, he joined the Department of Head and Neck Surgery at the Cancer Institute Hospital of the Japanese Foundation for Cancer Research (JFCR), and in 2001 he completed a clinical fellowship at the University of Pittsburgh. Since 2008, he has been affiliated with the National Cancer Center Hospital in Tokyo, where he was appointed Vice Director in 2021. In 2024, he assumed the presidency of the Japan Society for Head and Neck Cancer and currently serves on the Executive Committee of IFHNOS. He has authored 120 English-language papers, 121 Japanese-language papers, and 11 textbooks. His clinical and academic interests include sentinel node biopsy, head and neck sarcoma, open conservation surgery, skull base and upper mediastinal surgery, salvage surgery after chemoradiotherapy, surgical education, cancer registries, and terminal care for patients with head and neck cancer.</p>

<p></p>

<p>Bevan Yueh, MD, MPH, is the chief physician executive for University of Iowa Health Care. He is the President of the American Head & Neck Society. He was formerly the CEO for University of Minnesota Physicians and vice dean for clinical affairs for the University of Minnesota Medical School. He has clinical expertise in head and neck oncologic surgery and research expertise in clinical epidemiology and clinical trials.</p>

<p>Heikki Irjala is a Professor of Otorhinolaryngology – Head and Neck Surgery at the University of Turku, Turku, Finland. He has completed a fellowship in head and neck surgery and is currently working in reconstructive head and neck surgery and traumatology. He completed his PhD in 2002 on “Immunotherapeutic Approach to Cancer of the Head and Neck” and has since continued both translational and clinical research.</p>

<p>Michiel WM van den Brekel, MD PhD, graduated “cum laude” from the Medical Faculty of the University of Leuven (Belgium) in 1987. He did his Ph.D. cum laude at the Free University and wrote a thesis on “Imaging and Histophathology of Neck Node Metastases”. He was the first to study the value of ultrasound guided aspiration cytology in neck nodes. After his Otolaryngology-residency at the Free University in Amsterdam he did a Head and Neck Fellowship at the Netherlands Cancer Institute and the University of Toronto, Mount Sinai Hospital. From 1997 until 2000 he worked as a head and neck surgeon at the Free University Hospital and since 2000 in the Netherlands Cancer Institute in Amsterdam where he was chairman from 2009 until 2023. In 2011 he was appointed as Professor at the University of Amsterdam. His clinical research focuses on translational medicine, rehabilitation as well as imaging of head and neck cancer patients. He (co-)authored over 350 peer-reviewed papers and chapters.</p>